Screening of cardiovascular risk factors in patients with schizophrenia and patients treated with antipsychotic drugs: are we equally exhaustive as with the general population?

References

• Nordentoft M, Wahlbeck K, Hällgren J, et al. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One 2013;8(1):e55176.
   PubMed Web of Science ®Google Scholar
• Castillo Sánchez M, Fàbregas Escurriola M, Bergè Baquero D, et al. [Psychosis, cardiovascular risk and associated mortality: are we on the right track?]. Clin Investig Arterioscler 2014 Jan– Feb;26(1):23–32. Review. Spanish.
   Google Scholar
• Dipasquale S, Pariante CM, Dazzan P, et al. The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res 2013;47(2):197–207.
   PubMed Web of Science ®Google Scholar
• Foley DL, Morley KI. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch Gen Psychiatry 2011;68:609–16.
   PubMed Web of Science ®Google Scholar
• Hansen T, Ingason A, Djurovic S, et al. At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia. Biol Psychiatry 2011;70(1):59–63.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Miller BJ, Garcia-Rizo C, et al. Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits? Schizophr Bull 2012;38(2):280–4.
   PubMed Web of Science ®Google Scholar
• Smith DJ, Langan J, McLean G, et al. Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study. BMJ Open 2013;3(4):e002808. doi: 10.1136/ bmjopen-2013-002808
   Web of Science ®Google Scholar
• Bernardo M, Cañas F, Banegas JR, et al.; RICAVA Study Group. Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: a cross-sectional study in a low cardiovascular disease risk geographical area. Eur Psychiatry 2009;24(7):431–41.
   Google Scholar
• Laursen TM, Munk-Olsen T, Agerbo E, et al. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry 2009;66(7):713–20.
   PubMed Web of Science ®Google Scholar
• Druss BG, Bradford WD, Rosenheck RA, et al. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry 2001;58:565–72.
   PubMed Web of Science ®Google Scholar
• Castillo-Sánchez M, Fàbregas-Escurriola M, Bergè-Baquero D, et al. Schizophrenia, antipsychotic drugs and cardiovascular risk: Descriptive study in primary care. Eur Psychiatry 2015;30(4):535–41.
   PubMed Web of Science ®Google Scholar
• Bolíbar B, Fina Avilés F, Morros R, et al.; SIDIAP Group. [SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research]. Med Clin (Barc) 2012;138(14): 61721. Spanish.
   Google Scholar
• García-Gil Mdel M, Hermosilla E, Prieto-Alhambra D, et al. Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). Inform Prim Care 2011;19(3):135–45.
   PubMedGoogle Scholar
• [International Classification of Diseases and Related Health Problems (ICD), Tenth Revision, volume 1]. Washington, DC: Organización Panamericana de la Salud. 2003. Spanish. Available at: http://new.paho.org (http://iris.paho.org/xmlui/bitstream/handle/123456789/6282)
   Google Scholar
• R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2015. Available at: http://www.Rproject.org/.
   Google Scholar
• Sandström YK, Ljunggren G, Wändell P, et al. Psychiatric comorbidities in patients with hypertension–a study of registered diagnoses 2009-2013 in the total population in Stockholm County, Sweden. J Hypertens 2016;34(3):414–20.
   PubMed Web of Science ®Google Scholar
• Osborn DP, Nazareth I, King MB. Risk for coronary heart disease in people with severe mental illness: cross-sectional comparative study in primary care. Br J Psychiatry 2006;188:271–7.
   PubMed Web of Science ®Google Scholar
• Dickerson FB, McNary W, Brown CH, et al. Somatic healthcare utilization among adults with serious mental illness who are receiving community psychiatric services. Med Care 2003;41:560–70.
   PubMed Web of Science ®Google Scholar
• Baller JB, McGinty EE, Azrin ST, et al. Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence. BMC Psychiatry 2015;21;15:55. Review.
   Web of Science ®Google Scholar
• Leung JY, Barr AM, Procyshyn RM, et al. Cardiovascular side effects of antipsychotic drugs: the role of the autonomic nervous system. Pharmacol Ther 2012;135(2):113–22.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Delaffon V, Vancampfort D, et al. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med 2012;42:125–47.
   PubMed Web of Science ®Google Scholar
• Sáiz Ruiz J, Bobes García J, Vallejo Ruiloba J, et al.; Grupo de Trabajo sobre la Salud Física del Paciente con Esquizofrenia. [Consensus on physical health of patients with schizophrenia from the Spanish Societies of Psychiatry and Biological Psychiatry]. Actas Esp Psiquiatr 2008;36(5):251–64. Spanish.
   Google Scholar
• De Hert M, Dekker JM, Wood D, et al. Cardiovascular disease and diabetes in people with severe mental illness: position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 2009;24(6):412–24.
   PubMed Web of Science ®Google Scholar
• Heald A, Montejo AL, Millar H, et al. Management of physical health in patients with schizophrenia: practical recommendations. Eur Psychiatry 2010;25 Suppl 2:S41–5.
   PubMed Web of Science ®Google Scholar
• Morrato EH, Newcomer JW, Kamat S, et al. Metabolic screening after the American Diabetes Association’s consensus statement on antipsychotic drugs and diabetes. Diabetes Care 2009;32:1037–42.
   PubMed Web of Science ®Google Scholar
• Deuschle M, Paul F, Brosz M, et al. Assessment of cardiovascular disease risk in patients with schizophrenia spectrum disorders in German psychiatric hospitals: results of the pharmacoepidemiologic CATS study. Soc Psychiatry Psychiatr Epidemiol 2013 Aug;48(8):1283–8.
   PubMed Web of Science ®Google Scholar
• Valdés S, García-Torres F, Maldonado-Araque C, et al.; [email protected] study group. Prevalence of obesity, diabetes and other cardiovascular risk factors in Andalusia (southern Spain). Comparison with national prevalence data. The [email protected] study. Rev Esp Cardiol (Engl Ed) 2014;67(6):442–8.
   Google Scholar
• Ruiz-Ramos M, Escolar-Pujolar A, Mayoral-Sánchez E, et al. [Diabetes mellitus in Spain: death rates, prevalence, impact, costs and inequalities]. Gac Sanit 2006;20 Suppl 1:15–24. Review. Spanish.
   Google Scholar
• Bueno H, Hernáez R, Hernández AV. [Type 2 Diabetes Mellitus and Cardiovascular Disease in Spain: A Narrative Review]. Rev Esp Cardiol 2008;8 (C):53–61. Review. Spanish.
   Google Scholar
• García Iglesias A, Lozano Alonso JE, Álamo Sanz R, et al. [Trend in cardiovascular risk factors from 2004 to 2009 in the cohort of the Cardiovascular Disease Risk Study in Castilla y León (RECCYL)]. Angiologia 2015;67:259–65. Spanish.
   Google Scholar
• Beunza JJ, Martínez-González MA, Serrano-Martínez M, et al. [Incidence of hypertension in a cohort of Spanish university graduates: the SUN study]. Rev Esp Cardiol 2006;59(12):1331–4. Spanish.
   Google Scholar